These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 34023444)

  • 1. Natural flavonoid morin showed anti-bacterial activity against Vibrio cholera after binding with cell division protein FtsA near ATP binding site.
    Nag D; Dastidar DG; Chakrabarti G
    Biochim Biophys Acta Gen Subj; 2021 Aug; 1865(8):129931. PubMed ID: 34023444
    [TBL] [Abstract][Full Text] [Related]  

  • 2. FtsA-FtsZ interaction in Vibrio cholerae causes conformational change of FtsA resulting in inhibition of ATP hydrolysis and polymerization.
    Nag D; Chatterjee A; Chakrabarti G
    Int J Biol Macromol; 2020 Jan; 142():18-32. PubMed ID: 31790740
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A Modified ToxT Inhibitor Reduces Vibrio cholerae Virulence in Vivo.
    Woodbrey AK; Onyango EO; Kovacikova G; Kull FJ; Gribble GW
    Biochemistry; 2018 Sep; 57(38):5609-5615. PubMed ID: 30160100
    [TBL] [Abstract][Full Text] [Related]  

  • 4. FtsEX acts on FtsA to regulate divisome assembly and activity.
    Du S; Pichoff S; Lutkenhaus J
    Proc Natl Acad Sci U S A; 2016 Aug; 113(34):E5052-61. PubMed ID: 27503875
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Alkaline pH Increases Swimming Speed and Facilitates Mucus Penetration for Vibrio cholerae.
    Nhu NTQ; Lee JS; Wang HJ; Dufour YS
    J Bacteriol; 2021 Mar; 203(7):. PubMed ID: 33468594
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Suppression of Virulence of Toxigenic Vibrio cholerae by Anethole through the Cyclic AMP (cAMP)-cAMP Receptor Protein Signaling System.
    Zahid MS; Awasthi SP; Asakura M; Chatterjee S; Hinenoya A; Faruque SM; Yamasaki S
    PLoS One; 2015; 10(9):e0137529. PubMed ID: 26361388
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Selective and Efficient Elimination of
    Oh YT; Kim HY; Kim EJ; Go J; Hwang W; Kim HR; Kim DW; Yoon SS
    Front Cell Infect Microbiol; 2016; 6():156. PubMed ID: 27900286
    [No Abstract]   [Full Text] [Related]  

  • 8. Identification and characterization of VpsR and VpsT binding sites in Vibrio cholerae.
    Zamorano-Sánchez D; Fong JC; Kilic S; Erill I; Yildiz FH
    J Bacteriol; 2015 Apr; 197(7):1221-35. PubMed ID: 25622616
    [TBL] [Abstract][Full Text] [Related]  

  • 9. High-throughput screening and whole genome sequencing identifies an antimicrobially active inhibitor of Vibrio cholerae.
    Sergeev G; Roy S; Jarek M; Zapolskii V; Kaufmann DE; Nandy RK; Tegge W
    BMC Microbiol; 2014 Feb; 14():49. PubMed ID: 24568688
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Conjugated Linoleic Acid Reduces Cholera Toxin Production In Vitro and In Vivo by Inhibiting Vibrio cholerae ToxT Activity.
    Withey JH; Nag D; Plecha SC; Sinha R; Koley H
    Antimicrob Agents Chemother; 2015 Dec; 59(12):7471-6. PubMed ID: 26392502
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Modulating the Global Response Regulator, LuxO of
    Hema M; Vasudevan S; Balamurugan P; Adline Princy S
    Front Cell Infect Microbiol; 2017; 7():441. PubMed ID: 29075619
    [No Abstract]   [Full Text] [Related]  

  • 12. AlmG, responsible for polymyxin resistance in pandemic
    Henderson JC; Herrera CM; Trent MS
    J Biol Chem; 2017 Dec; 292(51):21205-21215. PubMed ID: 29101229
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In vivo fluid accumulation-inhibitory, anticolonization and anti-inflammatory and in vitro biofilm-inhibitory activities of methyl gallate isolated from Terminalia chebula against fluoroquinolones resistant Vibrio cholerae.
    Bag PK; Roy N; Acharyya S; Saha DR; Koley H; Sarkar P; Bhowmik P
    Microb Pathog; 2019 Mar; 128():41-46. PubMed ID: 30578837
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Small-molecule inhibitor of Vibrio cholerae virulence and intestinal colonization.
    Hung DT; Shakhnovich EA; Pierson E; Mekalanos JJ
    Science; 2005 Oct; 310(5748):670-4. PubMed ID: 16223984
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Vibrio cholerae CsrA Regulates ToxR Levels in Response to Amino Acids and Is Essential for Virulence.
    Mey AR; Butz HA; Payne SM
    mBio; 2015 Aug; 6(4):e01064. PubMed ID: 26242626
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Role of the FtsA C terminus as a switch for polymerization and membrane association.
    Krupka M; Cabré EJ; Jiménez M; Rivas G; Rico AI; Vicente M
    mBio; 2014 Nov; 5(6):e02221. PubMed ID: 25425238
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Activation of both acfA and acfD transcription by Vibrio cholerae ToxT requires binding to two centrally located DNA sites in an inverted repeat conformation.
    Withey JH; DiRita VJ
    Mol Microbiol; 2005 May; 56(4):1062-77. PubMed ID: 15853890
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Aerobic Metabolism in Vibrio cholerae Is Required for Population Expansion during Infection.
    Van Alst AJ; DiRita VJ
    mBio; 2020 Sep; 11(5):. PubMed ID: 32873763
    [No Abstract]   [Full Text] [Related]  

  • 19. Indole Inhibits ToxR Regulon Expression in
    Howard MF; Bina XR; Bina JE
    Infect Immun; 2019 Mar; 87(3):. PubMed ID: 30617203
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Vibrio cholerae infection, novel drug targets and phage therapy.
    Fazil MH; Singh DV
    Future Microbiol; 2011 Oct; 6(10):1199-208. PubMed ID: 22004038
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.